ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $34,000 | +25.9% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q3 2017 | $27,000 | -3.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $28,000 | -82.6% | 6,000 | -84.3% | 0.00% | -80.0% |
| Q1 2017 | $161,000 | -42.9% | 38,200 | -44.0% | 0.01% | -37.5% |
| Q4 2016 | $282,000 | -51.7% | 68,200 | -5.5% | 0.01% | -52.9% |
| Q3 2016 | $584,000 | +3.7% | 72,200 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $563,000 | -9.2% | 72,200 | -10.0% | 0.02% | -15.8% |
| Q1 2016 | $620,000 | -28.4% | 80,200 | 0.0% | 0.02% | -29.6% |
| Q4 2015 | $866,000 | +71.1% | 80,200 | +9.6% | 0.03% | +28.6% |
| Q3 2015 | $506,000 | -31.3% | 73,200 | -12.0% | 0.02% | -22.2% |
| Q2 2015 | $737,000 | +1149.2% | 83,200 | +1286.7% | 0.03% | +1250.0% |
| Q1 2015 | $59,000 | -19.2% | 6,000 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $73,000 | +21.7% | 6,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $60,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |